nach oben

Erschienen in:

16.09.2017 | Original Contribution

Interpersonal sensitivity and persistent attenuated psychotic symptoms in adolescence

verfasst von: Alice Masillo, M. Brandizzi, L. R. Valmaggia, R. Saba, N. Lo Cascio, J. F. Lindau, L. Telesforo, P. Venturini, D. Montanaro, D. Di Pietro, M. D’Alema, P. Girardi, P. Fiori Nastro

Erschienen in: European Child & Adolescent Psychiatry | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

Interpersonal sensitivity defines feelings of inner-fragility in the presence of others due to the expectation of criticism or rejection. Interpersonal sensitivity was found to be related to attenuated positive psychotic symptom during the prodromal phase of psychosis. The aims of this study were to examine if high level of interpersonal sensitivity at baseline are associated with the persistence of attenuated positive psychotic symptoms and general psychopathology at 18-month follow-up. A sample of 85 help-seeking individuals (mean age = 16.6, SD = 5.05) referred an Italian early detection project, completed the interpersonal sensitivity measure and the structured interview for prodromal symptoms (SIPS) at baseline and were assessed at 18-month follow-up using the SIPS. Results showed that individuals with high level of interpersonal sensitivity at baseline reported high level of attenuated positive psychotic symptoms (i.e., unusual thought content) and general symptoms (i.e., depression, irritability and low tolerance to daily stress) at follow-up. This study suggests that being “hypersensitive” to interpersonal interactions is a psychological feature associated with attenuated positive psychotic symptoms and general symptoms, such as depression and irritability, at 18-month follow-up. Assessing and treating inner-self fragilities may be an important step of early detection program to avoid the persistence of subtle but very distressing long-terms symptoms.

Fusar-Poli P, Nelson B, Valmaggia L, Yung AR, McGuire PK (2014) Comorbid depressive and anxiety disorders in 509 individuals with an at-risk mental state: impact on psychopathology and transition to psychosis. Schizophr Bull 40:120–131CrossRefPubMed

Salokangas RKR, Ruhrmann S, von Reventlow HG, Heinimaa M, Svirskis T, From T, Luutonen S, Juckel G, Linszen D, Dingemans P, Birchwood M, Patterson P, Schultze-Lutter F, Klosterkötter J (2012) EPOS group: axis I diagnoses and transition to psychosis in clinical high-risk patients EPOS project: prospective follow-up of 245 clinical high-risk outpatients in four countries. Schizophr Res 138:192–197CrossRefPubMed

Svirskis T, Korkeila J, Heinimaa M, Huttunen J, Ilonen T, Ristkari T, McGlashan T, Salokangas RKR (2005) Axis-I disorders and vulnerability to psychosis. Schizophr Res 75:439–446CrossRefPubMed

van Os J (2013) The dynamics of subthreshold psychopathology: implications for diagnosis and treatment. Am J Psychiatry 170:695–698CrossRefPubMed

Yung AR, Nelson B, Thompson A, Wood SJ (2010) The psychosis threshold in ultra high risk (prodromal) research: is it valid? Schizophr Res 120:1–6CrossRefPubMed

Fusar-Poli P, Carpenter WT, Woods SW, McGlashan TH (2014) Attenuated psychosis syndrome: ready for DSM-5.1? Ann Rev Clin Psychol 10:155–192CrossRef

Fusar-Poli P, Bonoldi I, Yung AR, Borgwardt S, Kempton MJ, Valmaggia L, Barale F, Caverzasi E, McGuire P (2012) Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk. Arch Gen Psychiatry 69:220–229CrossRefPubMed

Hartmann JA, Yuen HP, McGorry PD, Yung AR, Lin A, Wood SJ, Lavoie S, Nelson B (2016) Declining transition rates to psychotic disorder in “ultra-high risk” clients: investigation of a dilution effect. Schizophr Res 170:130–136CrossRefPubMed

Velthorst E, Nieman DH, Becker HE, van de Fliert R, Dingemans PM, Klaassen R, de Haan L, van Amelsvoort T, Linszen DH (2009) Baseline differences in clinical symptomatology between ultra high risk subjects with and without a transition to psychosis. Schizophr Res 109:60–65CrossRefPubMed

10.

Yung AR, Yuen HP, Berger G, Francey S, Hung TC, Nelson B, Phillips L, McGorry P (2007) Declining transition rate in ultra high risk (prodromal) services: dilution or reduction of risk? Schizophr Bull 33:673–681CrossRefPubMedPubMedCentral

11.

Addington J, Cornblatt BA, Cadenhead KS, Cannon TD, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Heinssen R (2011) At clinical high risk for psychosis: outcome for nonconverters. Am J Psychiatry 168:800–805CrossRefPubMedPubMedCentral

12.

Lin A, Wood SJ, Nelson B, Beavan A, McGorry P, Yung AR (2015) Outcomes of non-transitioned cases in a sample at ultra-high risk for psychosis. Am J Psychiatry 172:249–258CrossRefPubMed

13.

Simon AE, Velthorst E, Nieman DH, Linszen D, Umbricht D, de Haan L (2011) Ultra high-risk state for psychosis and non-transition: a systematic review. Schizophr Res 132:8–17CrossRefPubMed

14.

McGorry P, Nelson B (2016) Why we need a transdiagnostic staging approach to emerging psychopathology, early diagnosis, and treatment. JAMA Psychiatry 73:191–192CrossRefPubMed

15.

Rutigliano G, Valmaggia L, Landi P, Frascarelli M, Cappucciati M, Sear V, Rocchetti M, De Micheli A, Jones C, Palombini E, McGuire P, Fusar-Poli P (2016) Persistence or recurrence of non-psychotic comorbid mental disorders associated with 6-year poor functional outcomes in patients at ultra high risk for psychosis. J Affect Disord 203:101–110CrossRefPubMed

16.

Fusar-Poli P, Bechdolf A, Taylor MJ, Bonoldi I, Carpenter WT, Yung AR, McGuire P (2013) At risk for schizophrenic or affective psychoses? A meta-analysis of DSM/ICD diagnostic outcomes in individuals at high clinical risk. Schizophr Bull 39:923–932CrossRefPubMed

17.

van Os J, Linscott RJ, Myin-Germeys I, Delespaul P, Krabbendam L (2009) A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness–persistence–impairment model of psychotic disorder. Psychol Med 39:179–195CrossRefPubMed

18.

Ruhrmann S, Schultze-Lutter F, Klosterkotter J (2010) Probably at-risk, but certainly ill—advocating the introduction of a psychosis spectrum disorder in DSM-V. Schizophr Res 120:23–37CrossRefPubMed

19.

Woods SW, Miller TJ, McGlashan TH (2001) The “prodromal” patient: both symptomatic and at-risk. CNS Spectr 6:223–232CrossRefPubMed

20.

Boyce P, Parker G (1989) Development of a scale to measure interpersonal sensitivity. Aust N.Z. J Psychiatry 23:341–351PubMed

21.

Boyce P, Mason C (1996) An overview of depression-prone personality traits and the role of interpersonal sensitivity. Aust N. Z. J Psychiatry 30:90–103CrossRefPubMed

22.

Boyce P, Parker G, Barnett B, Cooney M, Smith F (1991) Personality as a vulnerability factor to depression. Br J Psychiatry 159:106–114CrossRefPubMed

23.

Häfner H, Riecher-Ro¨ssler A, Hambrecht M, Maurer K, Meissner S, Schmidtke A, Fa¨tkenheuer B, Lo¨ffler W, van der Heiden W (1992) IRAOS: an instrument for the assessment of onset and early course of schizophrenia. Schizophr Res 6:209–223CrossRefPubMed

24.

Hambrecht M, Häfner H, Loffler W (1994) Beginning schizophrenia observed by significant others. Soc Psychiatry Psychiatr Epidemiol 29:53–60PubMed

25.

Masillo A, Day F, Laing J, Howes O, Fusar-Poli P, Byrne M, Bhattacharyya S, Fiori Nastro P, Girardi P, McGuire PK, Valmaggia LR (2012) Interpersonal sensitivity in the at-risk mental state for psychosis. Psychol Med 42:1835–1845CrossRefPubMed

26.

Masillo A, Valmaggia LR, Saba R, Brandizzi M, Lindau JF, Solfanelli A, Curto M, Narilli F, Telesforo L, Kotzalidis GD, Di Pietro D, D’Alema M, Girardi P, Fiori Nastro P (2016) Interpersonal sensitivity and functioning impairment in youth at ultra-high risk for psychosis. Eur Child Adolesc Psychiatry 25:7–16CrossRefPubMed

27.

Valmaggia LR, Freeman D, Green C, Garety P, Swapp D, Antley A, Prescott C, Fowler D, Kuipers E, Bebbington P, Slater M, Broome M, McGuire P (2007) Virtual reality and paranoid ideations in people with an ‘at-risk mental state’ for psychosis. Br J Psychiatry 51:s63–s68CrossRef

28.

Valmaggia LR, Day F, Rus-Calafell M (2016) Using virtual reality to investigate psychological processes and mechanisms associated with the onset and maintenance of psychosis: a systematic review. Soc Psychiatry Psychiatr Epidemiol 51:921–936CrossRefPubMed

29.

Davidson M, Reichenberg A, Rabinowitz J, Weiser M, Kaplan Z, Mark M (1999) Behavioral and intellectual markers for schizophrenia in apparently healthy male adolescents. Am J Psychiatry 156:1328–1335PubMed

30.

Freeman D, Garety P (2014) Advances in understanding and treating persecutory delusions: a review. Soc Psychiatry Psychiatr Epidemiol 49:1179–1189CrossRefPubMedPubMedCentral

31.

Green CE, Freeman D, Kuipers E, Bebbington P, Fowler D, Dunn G, Garety P (2011) Paranoid explanations of experience: a novel experimental study. Behav Cogn Psychother 39:21–34CrossRefPubMed

32.

Brandizzi M, Schultze-Lutter F, Masillo A, Lanna A, Curto M, Lindau JF, Solfanelli A, Listanti G, Patanè M, Kotzalidis G, Gebhardt E, Meyer N, Di Pietro D, Leccisi D, Girardi P, Fiori Nastro P (2014) Self-reported attenuated psychotic-like experiences in help-seeking adolescents and their association with age, functioning and psychopathology. Schizophr Res 160:110–117CrossRefPubMed

33.

Loewy RL, Bearden CE, Johnson JK, Raine A, Cannon TD (2005) The prodromal questionnaire (PQ): preliminary validation of a self-report screening measure for prodromal and psychotic syndromes. Schizophr Res 77:141–149CrossRefPubMed

34.

Miller TJ, McGlashan TH, Rosen JL, Somjee L, Markovich PJ, Stein K, Woods SW (2002) Prospective diagnosis of the initial prodrome for schizophrenia based on the Structured Interview for Prodromal Syndromes: preliminary evidence of interrater reliability and predictive validity. Am J Psychiatry 159:863–865CrossRefPubMed

35.

Miller TJ, Zipursky RB, Perkins D, Addington J, Woods SW, Ka Hawkins, Hoffman R, Preda A, Epstein I, Addington D, Lindborg S, Marquez E, Tohen M, Breier A, McGlashan TH (2003) The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally. II. Baseline characteristics of the “prodromal” sample. Schizophr Res 61:19–30CrossRefPubMed

36.

Masillo A, Valmaggia LR, Lanna A, Brandizzi M, Lindau JF, Curto M, Solfanelli A, Kotzalidis GD, Patanè M, Godeas L, Leccisi D, Girardi P, Fiori Nastro P (2014) Validation of the Italian version of interpersonal sensitivity measure (IPSM) in adolescents and young adults. J Affect Disord 156:164–170CrossRefPubMed

37.

First MB, Spitzer RL, Gibbon M, Williams JBW (1995) Structured Clinical Interview For DSM-IV Axis 1 Disorders Patient Edition (SCID-I/PVersion2.0). New York State Psychiatric Institute, Biometrics Research Department, New York

38.

Kaufman J, Bismaher B, Brent DA, Rao U, Flynn C, Moreci P, Williamson D, Ryan N (1997) Schedule for affective disorders and schizophrenia for school- aged children—present and lifetime version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 36:980–988CrossRefPubMed

39.

Kretschmer E (1925) Physique and character: an investigation of the nature of constitution and of the theory of temperament. Harcourt, Brace, Oxford

40.

Sass L, Parnas J (2003) Schizophrenia, consciousness, and the self. Schizophr Bull 29:427–444CrossRefPubMed

41.

Nelson B, Parnas J, Sass LA (2014) Disturbance of minimal self (ipseity) in schizophrenia: clarification and current status. Schizophr Bull 40:479–482CrossRefPubMedPubMedCentral

42.

Nelson B, Thompson A, Yung AR (2012) Basic self-disturbance predicts psychosis onset in the ultra high risk for psychosis “prodromal” population. Schizophr Bull 38:1277–1287CrossRefPubMedPubMedCentral

43.

Nelson B, Sass LA, Skodlar B (2009) The phenomenological model of psychotic vulnerability and its possible implications for psychological interventions in the ultra-high risk (‘prodromal’) population. Psychopathology 42:283–292CrossRefPubMed

44.

Parnas J, Møller P, Kircher T, Thalbitzer J, Jansson L, Handest P, Zahavi D (2005) The examination of anomalies of self-experience (EASE). Psychopathology 38:236–258CrossRefPubMed

45.

M. Fagioli (1972) Death instinct and knowledge. Excerpts. L’ Asino d’oro, Rome 2010

46.

Maccari S, Polese D, Reynaert ML, Amici T, Morley-Fletcher S, Fagioli F (2017) Early-life experiences and the development of adult diseases with a focus on mental illness: the human birth theory. Neuroscience 7:232–251CrossRef

47.

Nelson B, Yuen HP, Wood SJ, Lin A, Spiliotacopoulos D, Bruxner A, Broussard C, Simmons M, Foley DL, Brewer WJ, Francey SM, Amminger GP, Thompson A, McGorry PD, Yung AR (2013) Long-term follow-up of a group at ultra high risk (“prodromal”) for psychosis: the PACE 400 study. JAMA Psychiatry 70:793–802CrossRefPubMed

48.

Nelson B (2014) Attenuated psychosis syndrome: don’t jump the gun. Psychopathology 47:292–296CrossRefPubMed

49.

Yung AR, Nelson B, Baker K, Buckby JA, Baksheev G, Cosgrave EM (2009) Psychotic-like experiences in a community sample of adolescents: implication for the continuum model of psychosis and prediction of schizophrenia. Aust N. Z. J Psychiatry 43:118–128CrossRefPubMed

50.

Woods SW, Addington J, Cadenhead KS, Cannon TD, Cornblatt BA, Heinssen R, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, McGlashan TH (2009) Validity of the prodromal risk syndrome for first psychosis: findings from the North American Prodrome Longitudinal Study. Schizophr Bull 35:894–908CrossRefPubMedPubMedCentral

Titel: Interpersonal sensitivity and persistent attenuated psychotic symptoms in adolescence
verfasst von: Alice Masillo
M. Brandizzi
L. R. Valmaggia
R. Saba
N. Lo Cascio
J. F. Lindau
L. Telesforo
P. Venturini
D. Montanaro
D. Di Pietro
M. D’Alema
P. Girardi
P. Fiori Nastro
Publikationsdatum: 16.09.2017
Verlag: Springer Berlin Heidelberg
Erschienen in: European Child & Adolescent Psychiatry / Ausgabe 3/2018
Print ISSN: 1018-8827
Elektronische ISSN: 1435-165X
DOI: https://doi.org/10.1007/s00787-017-1047-2

Neu im Fachgebiet Psychiatrie

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

23.04.2024 Depression antepartal oder postpartal Nachrichten

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

22.04.2024 DGIM 2024 Kongressbericht

Die Kombination aus Medikamenten und Psychotherapie gilt als effektivster Ansatz bei Depressionen. Das ist bei betagten Menschen nicht anders, trotz Besonderheiten.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2018

Attention networks in adolescent anorexia nervosa

Factors associated with the emotional health of children: high family income as a protective factor

The impact of comorbid mental health symptoms and sex on sleep functioning in children with ADHD

Towards a better understanding of the many facets of attention-deficit/hyperactivity disorder